Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy

Hidenori Tani, Shugo Tohyama, Yoshikazu Kishino, Hideaki Kanazawa, Keiichi Fukuda

研究成果: Article査読

抄録

The emergence of human induced pluripotent stem cells (hiPSCs) has revealed the potential for curing end-stage heart failure. Indeed, transplantation of hiPSC-derived cardiomyocytes (hiPSC-CMs) may have applications as a replacement for heart transplantation and conventional regenerative therapies. However, there are several challenges that still must be overcome for clinical applications, including large-scale production of hiPSCs and hiPSC-CMs, elimination of residual hiPSCs, purification of hiPSC-CMs, maturation of hiPSC-CMs, efficient engraftment of transplanted hiPSC-CMs, development of an injection device, and avoidance of post-transplant arrhythmia and immunological rejection. Thus, we developed several technologies based on understanding of the metabolic profiles of hiPSCs and hiPSC derivatives. In this review, we outline how to overcome these hurdles to realize the transplantation of hiPSC-CMs in patients with heart failure and introduce cutting-edge findings and perspectives for future regenerative therapy.

本文言語English
ページ(範囲)83-91
ページ数9
ジャーナルJournal of Molecular and Cellular Cardiology
164
DOI
出版ステータスPublished - 2022 3月

ASJC Scopus subject areas

  • 分子生物学
  • 循環器および心血管医学

フィンガープリント

「Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル